Doctor profile · Federal record
Dr. Daniel Massiah, M.D.
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Critical Care Medicine (Internal Medicine) Physician · Riverhead, NY
- NPI 1063485969
- Accepts Medicare
- MIPS 10.7 / 100 · 2023
- 28 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1333 Roanoke Ave Suite 202
Riverhead, NY 11901
(631) 591-3877
fax (631) 591-3880
Credentials & registration
- NPI registered
- February 2006 — 20 yrs on file
- Profile last updated
- March 19, 2025
- Year of graduation
- 1998 — 28 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- New York #235602
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1063485969. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,257
Distinct HCPCS
10
Medicare allowed
$117,620
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 475 | 217 | $148 | |
94640 |
Inhalation treatment for airway obstruction or sputum production | 124 | 121 | $11 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 122 | 119 | $46 | |
94727 |
Test to determine lung volumes using gas dilution or washout | 122 | 119 | $52 | |
94729 |
Test to examine how well the lungs exchange gases | 121 | 118 | $68 | |
99406 |
Smoking and tobacco use intensive counseling, 4-10 minutes | 90 | 38 | $17 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 70 | 46 | $105 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 68 | 68 | $195 | |
94664 |
Evaluation of use of breathing device | 38 | 32 | $21 | |
99442 |
Telephone medical discussion with physician, 11-20 minutes | 27 | 19 | $94 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 98. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$498
Transactions
9
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Inspire Medical Systems, Inc. | 3 | $291.82 | |
| Amgen Inc. | 1 | $107.44 | |
| GlaxoSmithKline, LLC. | 3 | $63.37 | |
| AstraZeneca Pharmaceuticals LP | 1 | $18.77 | |
| GENZYME CORPORATION | 1 | $16.64 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
628
Patients
148
Total drug cost
$480,403
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 224 | 56 | $281,006 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 106 | 39 | $4,950 |
| Anoro Ellipta (Umeclidinium Brm/Vilanterol Tr) | Brand | 58 | 12 | $52,919 |
| Prednisone | Generic | 48 | 15 | $304 |
| Stiolto Respimat (Tiotropium Br/Olodaterol Hcl) | Brand | 47 | 14 | $52,290 |
| Ventolin Hfa (Albuterol Sulfate) | Brand | 32 | 0 | $2,058 |
| Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) | Brand | 31 | 12 | $41,239 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 21 | 0 | $19,790 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 21 | 0 | $12,753 |
| Levofloxacin | Generic | 16 | 0 | $175 |
Frequently asked questions
What is Dr. Daniel Massiah's medical specialty?
Dr. Daniel Massiah practices Pulmonary Disease Physician in Riverhead, NY.
Where does Dr. Daniel Massiah practice?
Dr. Daniel Massiah practices at 1333 Roanoke Ave Suite 202, Riverhead, NY 11901. Office phone: 6315913877.
What is Dr. Daniel Massiah's NPI?
Dr. Daniel Massiah's National Provider Identifier (NPI) is 1063485969, issued by NPPES.
Does Dr. Daniel Massiah accept Medicare assignment?
Yes. Dr. Daniel Massiah accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Daniel Massiah commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Inhalation treatment for airway obstruction or sputum production (HCPCS 94640); Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS 94060). Source: CMS Medicare Physician & Other Practitioners file.